A potential role for the endothelin ETA receptor in salt-sensitive hypertension of the proANP gene-disrupted mouse

Molecular and Cellular Biochemistry

Volumn 275, Issue 1-2, 2005, Pages 57-66

  O'Tierney, P F ^a   Angelis, E ^a   Tse, M Y ^a   Pang, J J ^a   Adams, M A ^a   Pang, S C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Atrial natriuretic peptide; cGMP; Endothelin 1; Kidney; Salt sensitive hypertension

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR TYPE A; CYCLIC GMP; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; GUANYLATE CYCLASE; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; GENE DISRUPTION; GENOTYPE; HYPERTENSION; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY MEDULLA; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SALT INTAKE; SALT LOADING; UPREGULATION; URINE LEVEL; VASOCONSTRICTION; WILD TYPE;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOTTING, WESTERN; CYCLIC GMP; DISEASE MODELS, ANIMAL; GUANYLATE CYCLASE; HETEROZYGOTE; HOMOZYGOTE; HYPERTENSION; KIDNEY; MICE; MICE, KNOCKOUT; RECEPTOR, ENDOTHELIN A; RECEPTORS, PEPTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM, DIETARY; UP-REGULATION;

ANIMALIA;

EID: 22744440244     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-7716-3     Document Type: Article

References (28)

1. Atlas SA, Maack T: Effects of atrial natriuretic factor on the kidney and the renin-angiotensin-aldosterone system. Endocrinol Metab Clin North Am 16: 107-143, 1987
2. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28: 89-94, 1981
3. Stanton BA: Molecular mechanisms of ANP inhibition of renal sodium transport. Can J Physiol Pharmacol 69: 1546-1552, 1991
4. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O: Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679-681, 1995
5. Oliver PM, John SW, Purdy KE, Kim R, Maeda N, Goy MF, Smithies O: Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc Natl Acad Sci USA 95: 2547-2551, 1998
6. John SW, Veress AT, Honrath U, Chong CK, Peng L, Smithies O, Sonnenberg H: Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP. Am J Physiol 271: R109-R114, 1996
7. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
8. Vassileva I, Mountain C, Pollock DM: Functional role of ETB receptors in the renal medulla. Hypertension 41: 1359-1363, 2003
9. Kotelevtsev Y, Webb DJ: Endothelin as a natriuretic hormone: The case for a paracrine action mediated by nitric oxide. Cardiovasc Res 51: 481-488, 2001
10. Ferri C, Bellini C, Desideri G, Mazzocchi C, De Siati L, Santucci A: Elevated plasma and urinary endothelin-I levels in human salt-sensitive hypertension. Clin Sci (Lond) 93: 35-41, 1997
11. Rothermund L, Traupe T, Dieterich M, Kossmehl P, Yagil C, Yagil Y, Kreutz R: Nephroprotective effects of the endothelin ET(A) receptor antagonist darusentan in salt-sensitive genetic hypertension. Eur J Pharmacol 468: 209-216, 2003
12. Rothermund L, Luckert S, Kossmehl P, Paul M, Kreutz R: Renal endothelin ET(A)/ET(B) receptor imbalance differentiates salt-sensitive from salt-resistant spontaneous hypertension. Hypertension 37: 275-280, 2001
13. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M: Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105: 925-933, 2000
14. Melo LG, Veress AT, Chong CK, Pang SC, Flynn TG, Sonnenberg H: Salt-sensitive hypertension in ANP knockout mice: Potential role of abnormal plasma renin activity. Am J Physiol 274: R255-R261, 1998
15. Vera N, Tse MY, Watson JD, Sarda S, Steinhelper ME, John SW, Flynn TG, Pang SC: Altered expression of natriuretic peptide receptors in proANP gene disrupted mice. Cardiovasc Res 46: 595-603, 2000
16. Peterson GL: A simplification of the protein assay method of Lowry et al., which is more generally applicable. Anal Biochem 83: 346-356, 1977
17. Sangaralingham SJ, Pak BJ, Tse MY, Angelis E, Adams MA, Smallegange C, Pang SC: Expression of the translational repressor NAT1 in experimental models of cardiac hypertrophy. Mol Cell Biochem 245: 183-190, 2003
18. Tse MY, Watson JD, Sarda IR, Flynn TG, Pang SC: Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice. Mol Cell Biochem 219: 99-105, 2001
19. Ogawa T, Bruneau BG, Yokota N, de Bold ML, de Bold AJ: Tissue-specific regulation of renal and cardiac atrial natriuretic factor gene expression in deoxycorticosterone acetate-salt rats. Hypertension 30: 1342-1347, 1997
20. Ferrari P, Weidmann P, Ferrier C, Dietler R, Hollmann R, Piso RJ, Wey J, Shaw S: Dysregulation of atrial natriuretic factor in hypertension-prone man. J Clin Endocrinol Metab 71: 944-951, 1990
21. Chen S, Gardner DG: Osmoregulation of natriuretic peptide receptor signaling in inner medullary collecting duct. A requirement for p38 MAPK. J Biol Chem 277: 6037-6043, 2002
22. Ye Q, Chen S, Gardner DG: Endothelin inhibits NPR-A and stimulates eNOS gene expression in rat IMCD cells. Hypertension 41: 675-681, 2003
23. Ferri C, Bellini C, Desideri G, Giuliani E, De Siati L, Cicogna S, Santucci A: Clustering of endothelial markers of vascular damage in human salt-sensitive hypertension: Influence of dietary sodium load and depletion. Hypertension 32: 862-868, 1998
24. Moreau P, Schiffrin EL: Role of endothelins in animal models of hypertension: Focus on cardiovascular protection. Can J Physiol Pharmacol 81: 511-521, 2003
25. Skvorak JP, Nazian SJ, Dietz JR: Endothelin acts as a paracrine regulator of stretch-induced atrial natriuretic peptide release. Am J Physiol 269: R1093-R1098, 1995
26. Elijovich F, Laffer CL: Participation of renal and circulating endothelin in salt-sensitive essential hypertension. J Hum Hypertens 16: 459-467, 2002
27. Chrysant GS: High salt intake and cardiovascular disease: Is there a connection? Nutrition 16: 662-664, 2000
28. Weidmann P, Ferrari P, Allemann Y, Ferrier C, Shaw SG: Developing essential hypertension: A syndrome involving ANF deficiency? Can J Physiol Pharmacol 69: 1582-1591, 1991